Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
ME Therapeutics Holdings, Inc. (TSE:METX)
:METX
Holding TSE:METX?
Track your performance easily
METX Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$0.75 - C$7.50
Previous CloseN/A
Volume600.00
Average Volume (3M)772.00
Market Cap
N/A
Enterprise ValueC$67.77M
Total Cash (Recent Filing)$397.91K
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-1.72
Next Earnings
Jan 22, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.05
Shares Outstanding25,189,493
10 Day Avg. Volume435
30 Day Avg. Volume772
Standard Deviation0.89
R-Squared0.00388
Alpha0.32
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-171.80
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda-52.35
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
ME Therapeutics Holdings, Inc. News
PremiumCompany Announcements
ME Therapeutics Appoints Karim Lalji as CBOPremiumCompany Announcements
ME Therapeutics Expands Drug Development and FacilitiesPremiumCompany Announcements
ME Therapeutics Begins Testing mRNA Cancer TreatmentsPremiumCompany Announcements
ME Therapeutics Partners for mRNA Cancer TherapiesPremiumCompany Announcements
ME Therapeutics Showcases Innovations at Key EventsPremiumCompany Announcements
ME Therapeutics Celebrates CSE Bell-Ringing EventPremiumCompany Announcements
ME Therapeutics Awards Stock OptionsPremiumCompany Announcements
ME Therapeutics Enhances Investor OutreachOptions Prices
Currently, No data available
---
Ownership Overview
METX FAQ
What was ME Therapeutics Holdings, Inc.’s price range in the past 12 months?
ME Therapeutics Holdings, Inc. lowest stock price was C$0.75 and its highest was C$7.50 in the past 12 months.
What is ME Therapeutics Holdings, Inc.’s market cap?
Currently, no data Available
When is ME Therapeutics Holdings, Inc.’s upcoming earnings report date?
ME Therapeutics Holdings, Inc.’s upcoming earnings report date is Jan 22, 2025 which is in 8 days.
How were ME Therapeutics Holdings, Inc.’s earnings last quarter?
Currently, no data Available
Is ME Therapeutics Holdings, Inc. overvalued?
According to Wall Street analysts ME Therapeutics Holdings, Inc.’s price is currently Overvalued.
Does ME Therapeutics Holdings, Inc. pay dividends?
ME Therapeutics Holdings, Inc. does not currently pay dividends.
What is ME Therapeutics Holdings, Inc.’s EPS estimate?
ME Therapeutics Holdings, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does ME Therapeutics Holdings, Inc. have?
ME Therapeutics Holdings, Inc. has 25,189,493 shares outstanding.
What happened to ME Therapeutics Holdings, Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of ME Therapeutics Holdings, Inc.?
Currently, no hedge funds are holding shares in TSE:METX
---
Company Description
ME Therapeutics Holdings, Inc.
ME Therapeutics is a pre-clinical biopharmaceutical company dedicated to the discovery and development of novel cancer immunotherapies. Using our combined expertise in tumour immunology, T cell biology and myeloid cell development, we are developing biological and small molecule drugs to target novel pathways involved in cancer-induced immune suppression. Our therapies have the potential to work on their own and in combination with other cancer immunotherapies across several cancer types.
---
Technical Analysis
---